Nachrichten zur Merck & Co. Inc. Aktie

Merck & Co Aktie: Wichtiger Durchbruch!

New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Wolfe Research:Wolfe-Research-Analystin Alexandria Hammond habe das Kursziel für die Aktie von Merck…

Merck & Co Aktie: Gewaltiges Potenzial!

New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Argus Research:Argus-Analyst Jasper Hellweg habe das Kursziel für die Aktie von Merck…

Why Did RUM, MRK, NEM Stocks Jump To 52-Week Highs Today?

Rum Group, Merck, and Newmont shares surged to annual highs amid positive company catalysts, Wall Street optimism, and a rise…

Merck & Co Aktie: Krebsimpfstoff entfacht Milliardenfantasie!

New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Goldman Sachs:Goldman Sachs habe das Kursziel für die Aktie von Merck &…

Pivotal-Point Nachverfolgung Merck & Co. (MRK): Allzeithoch nach Phase-3-Erfolg - Pharmaziegigant profitiert von Moderna-mRNA-Krebsimpfstoff

Merck & Co. zählt weltweit zu den führenden Pharmaunternehmen mit Fokus auf Onkologie, Impfstoffe und Tiergesundheit. Bekanntester Blockbuster ist die…

Myriad Genetics and Moderna Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after shares across biotech and big pharma cooled further as traders…

A cancer vaccine years in the making just proved itself

Merck added billions in a single day after its Moderna-partnered cancer vaccine cleared a major hurdle.…

Merck & Co. Aktienanalyse: Keytruda-Patentablauf verliert seinen Schrecken - BofA bleibt bei "buy"

Bad Marienberg (www.aktiencheck.de) - Die Aktie von Merck & Co. Inc. (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol: 6MK, NYSE-Symbol: MRK) rückt…

Merck & Co Aktie: RBC Capital zieht nach der Rally die Reißleine!

Bad Marienberg (www.aktiencheck.de) - Ausgerechnet nach einem wissenschaftlichen Paukenschlag tritt RBC Capital bei Merck & Co Inc. (ISIN: US58933Y1055, WKN:…

Merck & Co Aktie: Krebsimpfstoff eröffnet riesige Chancen

Toronto (www.aktiencheck.de) - Merck & Co-Aktienanalyse von BMO Capital Markets:BMO Capital habe das Kursziel für die Aktie von Merck &…

Moderna Aktie: William Blair vollzieht die Kehrtwende - Krebs-Durchbruch verändert die Story!

Bad Marienberg (www.aktiencheck.de) - Was für eine Woche für Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol: MRNA)! Erst…

Merck vs. J&J: Which Healthcare Giant Should Investors Choose?

JNJs diversified portfolio and pipeline strength offer an edge over MRK as both face patent expiration challenges.…

Can Mercks New Drugs Offer Growth Cushion Ahead of Keytruda LOE?

MRKs growing pipeline, acquired assets and new product launches are gaining traction as it builds a diversified growth base ahead…

Cancer vaccine breakthrough at Moderna raises hopes for Scancells melanoma programme

A landmark trial success for Moderna and Mercks cancer vaccine has strengthened the case for Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF,…

Merck is a buy as strong cancer drug pipeline offsets Keytruda patent expiration, Morgan Stanley says

Merck, which makes the popular cancer treatment Keytruda, is poised to gain ground as its pipeline drugs get close to…

Merck & Co Aktie: Fit für Post-Keytruda- Ära?

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), streicht…

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.…

Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data

Today, Aug. 19, 2026, Modernas personalized cancer vaccine met its late-stage goal, with the company and Merck planning an FDA…

Moderna, Merck breakthrough could usher in wave of cancer vaccines

Merck and Modernas success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of…

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.…

Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Heres What That Means for Investors.

The treatment combines an mRNA shot with Mercks Keytruda.…

Merck & Co.: mRNA-Erfolg mit Moderna könnte Keytruda neuen Rückenwind geben

Moderna und Merck überzeugen mit Phase-3-Studiendaten zur Kombination des mRNA-Krebsimpfstoffs Intismeran und der Immuntherapie Keytruda. Das 2. Quartal überzeugte…

Merck, Moderna say melanoma skin cancer vaccine meets goals in large trial

Merck and Moderna said on Wednesday a study of a personalized mRNA vaccine combined with the immunotherapy drug Keytruda reduced…

Moderna shares soar as mRNA cancer vaccine succeeds in late-stage trial

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) and Merck & Co Inc (NYSE:MRK, XETRA:6MK) said Wednesday their personalized mRNA cancer vaccine, intismeran, combined...…

From COVID to Cancer: Moderna Scores Melanoma Breakthrough

By successfully applying individualized mRNA technology to train the immune system against recurring tumor cells, Moderna and Merck have opened…

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

Shares of Moderna (MRNA) and Merck (MRK) are soaring Wednesday after the companies reported a potentially historic breakthrough for their…

ACHV: Looking Ahead to Resubmission

By John Vandermosten, CFANASDAQ: ACHVREAD THE FULL ACHV RESEARCH REPORTAchieve Life Sciences, Inc. (NASDAQ: ACHV) reported second quarter results, introducing…

Merck EVP DeLuca sells $5.9m in stock

Merck EVP DeLuca sells $5.9m in stock…

Merck & Co Aktie: Pipeline-Erfolge lösen Hochstufung aus

Tokio (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Daiwa Capital Markets:Die Analysten von Daiwa stufen die Aktie von Merck & Co…

TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises

Bio-Technes Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in…

Merck Aktie: Bewertungslücke geschlossen

Wien (www.aktiencheck.de) - Merck-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), streicht in einer…

LGND: XOMA Acquisition Closed

By John Vandermosten, CFANASDAQ: LGNDREAD THE FULL LGND RESEARCH NOTELigand Pharmaceuticals, Inc. (NASDAQ: LGND) reported second quarter 2026 results boasting…

Merck Aktie: Halbleiterboom treibt Gewinn um 9,4% - Ausblick erneut angehoben

Wien (www.aktiencheck.de) - Merck-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

Eli Lilly erhöht Umsatzprognose - Zahlen von SpaceX kommen an der Börse schlecht an - Merck hebt Ausblick an

Wien (www.aktiencheck.de) - SpaceX (-13,6%) veröffentlichte gestern erstmals als börsennotiertes Unternehmen Geschäftszahlen, so die Analysten der Raiffeisen Bank International AG…

Quartalszahlen: Merck hebt nach Ergebnissprung Jahresziele an

Der Pharma- und Technologiekonzern korrigiert nach überraschend starken Zahlen seine Prognose zum zweiten Mal in diesem Jahr nach oben. Auch…

ROUNDUP: Neue Arzneien geben US-Pharmakonzern Merck & Co Schub

RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co hat im zweiten Quartal von einer starken…

Neue Arzneien geben US-Pharmakonzern Merck & Co Schub - Neue Jahresziele

RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co hat im zweiten Quartal von einer starken…

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.…

Stocks making the biggest moves premarket: McDonalds, Caterpillar, Palantir, Merck & more

These are the stocks posting the largest moves in early trading.…

MRK Q2 Earnings & Sales Beat Estimates, 26 Sales View Raised

Merck beat Q2 earnings and sales estimates as strong oncology and newer products lift results, prompting the company to raise…

Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?

Amgen, Pfizer, Eli Lilly, Merck and Novo Nordisk are set to report Q2 results this week after a strong start…

Earnings Preview: Merck (MRK) Q2 Earnings Expected to Decline

Merck (MRK) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Merck (MRK) Declines More Than Market: Some Information for Investors

Merck (MRK) concluded the recent trading session at $124.4, signifying a -2.43% move from its prior days close.…

Merck (MRK) Stock Sinks As Market Gains: Heres Why

In the closing of the recent trading day, Merck (MRK) stood at $123.54, denoting a -1.22% move from the preceding…

Top Research Reports for Tesla, Bank of America & Merck

Tesla, Bank of America and Merck lead todays featured research, highlighting growth drivers, risks and outlooks shaping these widely watched…

Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade

Merck (MRK) concluded the recent trading session at $126.78, signifying a -2.15% move from its prior days close.…

House committee investigates Merck, AbbVie over China trials

Five of the biggest names in American pharma just got a deadline from Washington. The House Select Committee on China…

Merck & Co Aktie: Hoffnungen auf neuen Lungenkrebs-Blockbuster

Charlotte (www.aktiencheck.de) - Merck & Co-Aktienanalyse der Bank of America (BofA):BofA habe das Kursziel für die Aktie von Merck &…

Merck Aktie: 11,3 Mrd. USD-Deal stärkt Life-Science-Geschäft - Kommt der Ausbruch auf neue Hochs?

Frankfurt (www.aktiencheck.de) - Merck-Aktienanalyse von XTB:Jens Klatt, Marktanalyst bei XTB, nimmt die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990,…

Stocks making the biggest moves premarket: AeroVironment, Strategy, Merck & more

These are the stocks posting the largest moves premarket.…